dolasetron
Selected indexed studies
- Dolasetron. (, 2006) [PMID:33630484]
- Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. (Drugs, 1997) [PMID:9257083]
- Dolasetron overdose resulting in prolonged QTc interval and severe hypotension: a case report and literature review. (Emerg Med J, 2007) [PMID:17582056]
_Worker-drafted node — pending editorial review._
Connections
dolasetron is a side effect of
Sources
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. (2020) pubmed
- Dolasetron. (2006) pubmed
- Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. (1997) pubmed
- Dolasetron overdose resulting in prolonged QTc interval and severe hypotension: a case report and literature review. (2007) pubmed
- Dolasetron: a new option for nausea and vomiting. (2000) pubmed
- Dolasetron for chemo nausea. (2001) pubmed
- Palonosetron. (2004) pubmed
- Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist. (1997) pubmed
- Dolasetron decreases postoperative nausea and vomiting after breast surgery. (2002) pubmed
- PMID:25610941 (2014) pubmed